Candela receives new policy on cryosurgery from American Urological Association; Cryosurgical treatment of prostate disease no longer experimental status for reimbursement.WAYLAND, Mass.--(BUSINESS WIRE)--Aug. 14, 1996--Candela Corp. (Nasdaq:CLZR) has received notification of the American Urological Association (AUA AUA American Urological Association, see there )'s decision to no longer view cryosurgery cryosurgery (krī`ōsr'jərē), bloodless surgical technique using a supercooled probe to destroy diseased or superfluous tissue. as an experimental and investigational procedure, legitimizing it as one method of treatment for prostate disease, the company announced today. Gerard E. Puorro, Candela's president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , said, "We are delighted with the AUA's revised judgement regarding cryosurgery. The procedure offers patients and additional choice in the array of available prostate disease treatments. We are encouraged by this change in policy, and believe it is an important step forward to more extensive acceptance of cryosurgery by health insurance carriers as a reimbursable treatment." Charles F. McKiel, Jr. immediate past president of the American Urological Association, conveyed the revised policy in a recent letter as, "Cryosurgical treatment of the prostate is one of the methods of management of adrenocarcinoma of the protstate. The long-term curative efficacy of this treatment modality treatment modality Medtalk The method used to treat a Pt for a particular condition has not been established. When used, appropriate disclosure of facts regarding all other treatments for prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. should be made to the patient." The American Urological Association is the official representative organization of practicing urologists in the United States that aims to, "foster the highest standards of urologic care through education, research, and the representation of the membership in the formulation of health care policy." The AUA also publishes several publications covering medical practice and health policy, and annually hosts the most complete and largest urological conference in the world. Cryosurgery with the Candela candela (kăndĕ`lə), in weights and measures: see candle. A unit of measurement of the intensity of light. Part of the SI system of measurement, one candela (cd) is the monochromatic radiation of 540THz with a radiant intensity Cryosurgical System uses liquid nitrogen to freeze and destroy diseased prostate cells. It has been done as a minimally invasive procedure Minimally invasive surgical procedures avoid open invasive surgery in favor of closed or local surgery with less trauma. These procedures involve use of laparoscopic devices and remote-control manipulation of instruments with indirect observation of the surgical field through an , usually involving only a few days of recovery, and costs about one-third to one-half as much as traditional surgery or radiation. Candela Corp. is an increasingly diversified, international company that provides clinical solutions to the dermatology, plastic surgery, and urology urology Medical specialty dealing with the urinary system and male reproductive organs. It traces its origin to medieval lithologists, itinerant healers who specialized in surgical removal of bladder stones. markets through medical laser products and services, skin care centers and spas, and cryogenic surgery products. Founded in 1970, the company recently changed its name from Candela Laser Corp. For more information, visit Candelas's web site at http://www.clzr.com CONTACT: Candela Corp. Gerard E. Puorro, 508/358-7400 x488 or Richard J. Olsen, 508/358-7400 x224 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion